Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

595 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of cardiovascular outcomes between SGLT2 inhibitors in diabetes mellitus.
Suzuki Y, Kaneko H, Okada A, Itoh H, Matsuoka S, Fujiu K, Michihata N, Jo T, Takeda N, Morita H, Kamiya K, Matsunaga A, Ako J, Node K, Yasunaga H, Komuro I. Suzuki Y, et al. Among authors: ako j. Cardiovasc Diabetol. 2022 May 18;21(1):67. doi: 10.1186/s12933-022-01508-6. Cardiovasc Diabetol. 2022. PMID: 35585590 Free PMC article.
Diagnostic implication of change in b-type natriuretic peptide (BNP) for prediction of subsequent target lesion revascularization following silorimus-eluting stent deployment.
Hasumi E, Iwata H, Kohro T, Manabe I, Kinugawa K, Morisaki N, Ando J, Sawaki D, Takahashi M, Fujita H, Yamashita H, Ako J, Hirata Y, Komuro I, Nagai R. Hasumi E, et al. Among authors: ako j. Int J Cardiol. 2013 Sep 30;168(2):1429-34. doi: 10.1016/j.ijcard.2012.12.046. Epub 2013 Jan 7. Int J Cardiol. 2013. PMID: 23302112
Quadriceps Strength as a Predictor of Mortality in Coronary Artery Disease.
Kamiya K, Masuda T, Tanaka S, Hamazaki N, Matsue Y, Mezzani A, Matsuzawa R, Nozaki K, Maekawa E, Noda C, Yamaoka-Tojo M, Arai Y, Matsunaga A, Izumi T, Ako J. Kamiya K, et al. Among authors: ako j. Am J Med. 2015 Nov;128(11):1212-9. doi: 10.1016/j.amjmed.2015.06.035. Epub 2015 Jul 11. Am J Med. 2015. PMID: 26169888
Rationale and design of a randomized trial to test the safety and non-inferiority of canagliflozin in patients with diabetes with chronic heart failure: the CANDLE trial.
Tanaka A, Inoue T, Kitakaze M, Oyama J, Sata M, Taguchi I, Shimizu W, Watada H, Tomiyama H, Ako J, Sakata Y, Anzai T, Uematsu M, Suzuki M, Eguchi K, Yamashina A, Saito Y, Sato Y, Ueda S, Murohara T, Node K. Tanaka A, et al. Among authors: ako j. Cardiovasc Diabetol. 2016 Apr 4;15:57. doi: 10.1186/s12933-016-0381-x. Cardiovasc Diabetol. 2016. PMID: 27044332 Free PMC article. Clinical Trial.
Rationale and design of a multicenter randomized study for evaluating vascular function under uric acid control using the xanthine oxidase inhibitor, febuxostat: the PRIZE study.
Oyama J, Tanaka A, Sato Y, Tomiyama H, Sata M, Ishizu T, Taguchi I, Kuroyanagi T, Teragawa H, Ishizaka N, Kanzaki Y, Ohishi M, Eguchi K, Higashi Y, Yamada H, Maemura K, Ako J, Bando YK, Ueda S, Inoue T, Murohara T, Node K; PRIZE Study Investigators. Oyama J, et al. Among authors: ako j. Cardiovasc Diabetol. 2016 Jun 18;15:87. doi: 10.1186/s12933-016-0409-2. Cardiovasc Diabetol. 2016. PMID: 27317093 Free PMC article. Clinical Trial.
A Single Session of Neuromuscular Electrical Stimulation Enhances Vascular Endothelial Function and Peripheral Blood Circulation in Patients With Acute Myocardial Infarction.
Tanaka S, Masuda T, Kamiya K, Hamazaki N, Akiyama A, Kamada Y, Maekawa E, Noda C, Yamaoka-Tojo M, Ako J. Tanaka S, et al. Among authors: ako j. Int Heart J. 2016 Dec 2;57(6):676-681. doi: 10.1536/ihj.15-493. Epub 2016 Nov 4. Int Heart J. 2016. PMID: 27818472 Free article. Clinical Trial.
595 results